Skip to content

Written by Sarah Collins · Every article cited · Reviewed on a schedule

How we source
PCOSguides
All topics

1000 articles planned across 8 sections. Each one carries a minimum of three primary sources.

Zone 2 Cardio for PCOS: What the Aerobic-Base Case Has Behind It

15 min read

Written by Sarah CollinsChecked against the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOSLast reviewed Published

A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.

The short answer

No trial has tested zone 2 (roughly 60–70% max heart rate) cardio specifically in PCOS. The closest evidence is a 36% HOMA-IR drop from vigorous-intensity exercise across 11 pooled trials — a higher intensity than zone 2. Zone 2 still has a mechanistic case through skeletal muscle glucose uptake, and it beats no cardio at all.

What is zone 2 cardio, and why is it being asked about for PCOS specifically?

Zone 2 refers to an aerobic-intensity band, roughly 60–70% of maximum heart rate, at which you can hold a full conversation without gasping and effort feels sustainable for 30 minutes or more — a definition borrowed from general endurance-training science, not a PCOS-specific classification. It has become a popular framing for “easy cardio done consistently,” on the theory that training mostly at this intensity builds an aerobic base and improves fat oxidation and mitochondrial density over months, without the recovery cost of harder sessions.

The honest starting point for a PCOS reader is that no trial has tested zone 2 training as its own defined protocol in a PCOS population. The PCOS exercise literature groups intensities as “vigorous,” “moderate,” or occasionally “light,” not by heart-rate zone the way general endurance coaching does. This article builds the zone 2 case from the mechanism and from the closest available intensity-matched PCOS trials, and says plainly where that reasoning runs out.

What is the actual mechanism zone 2 training is supposed to work through?

Skeletal muscle handles roughly 75 to 80% of the glucose the body clears from the bloodstream once insulin is released, measured directly with PET imaging and a euglycaemic clamp in 326 adults without diabetes, and skeletal muscle insulin resistance is described as the primary defect underlying type 2 diabetes in the clamp-study literature more broadly. Any aerobic training, regardless of intensity, forces working muscle to take up glucose through a pathway that does not depend heavily on insulin — a contraction-driven route that operates even in an insulin-resistant state. Sustained lower-intensity work is theorized to build this capacity through a different route than intervals: more time under aerobic load per session, more total weekly volume tolerated because recovery cost is lower, and — in general exercise physiology, outside PCOS specifically — greater mitochondrial density and fat-oxidation capacity built up over months of accumulated lower-intensity volume.

That mechanism is real and well-established in general exercise physiology. What it does not have, specifically for PCOS, is a trial that isolated zone 2 intensity, measured HOMA-IR or fasting insulin before and after, and reported a result the way the vigorous-intensity trials below did.

What do the closest available PCOS trials actually show?

Table 1 — PCOS exercise-intensity trials, and where zone 2 would sit relative to each.
Intensity testedTrial baseEffect on HOMA-IRWhere zone 2 sits
Vigorous-intensity aerobic11 trials, 307 women (meta-analysis)−36.2% vs controlAbove zone 2 — this is roughly 70–85%+ max heart rate
Moderate-intensity steady-state16 pooled studies, n=159 for HOMA-IR−0.341, trend only, not statistically significantClosest tested proxy — overlaps the top of zone 2 and moves into zone 3
HIIT (pooled)16 pooled studies, n=60 for HOMA-IR−0.257, not statistically significantWell above zone 2 by definition
Resistance training alone19-RCT network meta-analysis, 808 womenRanked least effective of six modalities for HOMA-IRNot aerobic; not comparable directly

The 36.2% HOMA-IR reduction from vigorous-intensity aerobic exercise, pooled across 11 trials and 307 women with PCOS, is the single largest and best-supported effect in the PCOS exercise literature — and it is a higher intensity than zone 2 by definition. A separate systematic review pooling 16 studies found neither HIIT (60 women) nor moderate-intensity steady-state exercise (159 women) reached statistical significance for HOMA-IR, though moderate intensity showed a trend toward improvement and significantly improved cardiorespiratory fitness where HIIT did not. Zone 2 sits at or below what most of these trials label “moderate” — meaning the honest read is that the PCOS-specific trial evidence for anything at or below zone 2’s intensity band is a non-significant trend, not an established effect the way vigorous intensity has one.

Does that mean zone 2 cardio is a waste of time for PCOS?

No — it means zone 2’s evidence base is different in kind, not necessarily weaker in practice for every goal. A 2025 Bayesian network meta-analysis of 19 randomised trials in 808 women with PCOS compared six exercise types head-to-head for HOMA-IR and found aerobic-resistance combinations and moderate-intensity continuous training both outperformed resistance training alone, even though vigorous and HIIT approaches ranked higher still. Lower-intensity aerobic work has a real place in that ranking — just not at the top, and not with a trial dosing it precisely at 60–70% max heart rate the way this article’s zone 2 framing implies.

Zone 2’s practical case rests on three things the trials above do not directly contradict: it is sustainable for longer sessions and more weekly volume than vigorous work, it carries a lower injury and burnout risk for someone new to structured cardio, and it is a reasonable on-ramp toward the vigorous intensity that does have the strongest PCOS-specific trial support. None of those three claims needs a PCOS-specific zone 2 trial to be true — they follow from general training-load principles and from the fact that vigorous intensity is easier to sustain once an aerobic base exists.

How do you actually find your zone 2, without a lab test?

Table 2 — practical ways to estimate zone 2, from least to most precise.
MethodHowPrecision
Talk testYou can hold a full sentence, not just single words, without gaspingLow — a reasonable starting filter, not a number
Estimated max heart rate220 minus age, then 60–70% of that numberModerate — population formula, individual variation is real
Heart-rate reserve (Karvonen)(Max HR − resting HR) × 0.6–0.7, plus resting HRBetter — accounts for your own fitness baseline
Lab-tested ventilatory or lactate thresholdA supervised exercise-physiology testHighest — not accessible or necessary for most people starting out

None of these methods have been validated specifically in a PCOS population, but none of them need to be — heart-rate zone estimation is general exercise physiology, not a PCOS-specific measurement. The talk test is the easiest to use without any equipment: if you can speak in full sentences but would rather not sing, you are likely in or near zone 2.

What does a realistic zone 2 week look like alongside the rest of a PCOS plan?

Given that vigorous intensity carries the strongest PCOS-specific HOMA-IR evidence and zone 2’s case is mechanistic and volume-based rather than dosed and proven, the more defensible plan combines both rather than choosing one exclusively. A full ranking of PCOS exercise modalities by what actually moved insulin resistance in trials is covered in depth separately, including where resistance training fits regardless of this specific aerobic question. Strength training’s own PCOS trial base and a beginner programme are covered on their own terms here if resistance work is the piece missing from your week.

A reasonable structure: two to three sessions a week at vigorous intensity, where the trial evidence is strongest, and two to three additional sessions at zone 2, sized to fit around recovery capacity and schedule rather than replacing the vigorous sessions. Zone 2’s lower recovery cost is what makes that additional volume tolerable in the first place — the same reason it is used as a volume-building tool in general endurance training. Whether running specifically carries any additional consideration in PCOS is addressed on its own terms if that is your preferred zone 2 modality.

How long should a zone 2 session actually be, and how often?

General endurance-training literature outside PCOS typically dosages zone 2 in sessions of 30 to 90 minutes, two to four times weekly, on the theory that time under aerobic load — not just intensity — is what drives the mitochondrial and fat-oxidation adaptations this training style is built around. No PCOS trial has tested that specific duration-and-frequency combination, so the numbers below are drawn from general exercise-physiology practice, applied to a PCOS reader honestly rather than presented as PCOS-dosed.

Table 3 — a starting zone 2 structure, built from general exercise-physiology practice, not a PCOS-specific trial.
WeekSession lengthFrequencyNote
1–220–30 minutes2x/weekEstablish the pace using the talk test before adding duration
3–430–45 minutes2–3x/weekAdd time before adding frequency
5–845–60 minutes3x/weekThis is where general endurance literature places early aerobic-base adaptations, not a PCOS-confirmed timepoint

Does zone 2 need to be fasted, or does eating first matter?

There is no PCOS trial on fasted zone 2 training specifically, and the general evidence available does not support the idea that training fasted is uniquely risky for insulin sensitivity — if anything, it points the other way in a non-PCOS population. In healthy young men following a six-week high-fat, calorie-surplus diet, endurance training done in a fasted state improved whole-body glucose tolerance and insulin sensitivity significantly more than the same training done after eating carbohydrate, though that specific finding was run in men on a specific hypercaloric diet, not in PCOS — it cannot be read as direct proof that fasted zone 2 helps PCOS, but it undercuts the assumption that fasted cardio is dangerous for insulin handling specifically, which is the actual concern most fasted-cardio worry in PCOS content is built on. Whether to train fasted is more reasonably decided by personal tolerance and how you feel during the session than by an assumed metabolic risk that the available evidence does not support.

How does zone 2 compare with walking, since both are described as “low intensity”?

Zone 2 and walking overlap in intensity for some people but are not interchangeable terms — zone 2 is a heart-rate-defined band that a fit person might only reach while jogging or cycling briskly, while an unfit or deconditioned person might reach the same heart-rate zone while walking briskly uphill. Post-meal walking has its own, more directly PCOS-relevant evidence — a specific, well-documented effect on blood sugar timing covered in depth elsewhere — and the two are not competing recommendations. A short post-meal walk addresses a specific glucose-timing window; zone 2 as described in this article is about sustained, longer-duration aerobic sessions building volume over weeks. Someone can reasonably do both: a short walk after each meal, and two to three longer zone 2 sessions weekly for the aerobic-base case described above.

Is there any PCOS-specific evidence for sustained lower-intensity aerobic work at all?

Yes, though it measures a different outcome than insulin resistance, and it does not name a heart-rate zone. A 2016 trial found 16 weeks of structured aerobic exercise increased parasympathetic modulation and decreased sympathetic modulation on heart-rate-variability measures in women with PCOS, independent of any change in BMI, fasting insulin, or testosterone — meaning the autonomic nervous system benefit showed up even without a corresponding metabolic-marker change, which argues for sustained aerobic training having value beyond the insulin-resistance lens this article has focused on so far. That trial did not specify a heart-rate zone matching the zone 2 definition used here, and its intensity is better described as “structured aerobic exercise” than as a dosed zone 2 protocol — but it is real, PCOS-specific evidence that sustained aerobic training below vigorous intensity produces a measurable physiological change, on a different marker than HOMA-IR.

Where does phenotype change this?

If your PCOS pattern is insulin-resistant, the vigorous-intensity trial evidence above is the higher-leverage lever for HOMA-IR specifically, and zone 2 should be framed as additive volume rather than a replacement for that harder work. If your pattern is adrenal-androgen-predominant, a lower, more consistent training intensity may be the more defensible default for reasons unrelated to insulin resistance — the specific reasoning, built around DHEAS rather than insulin, is covered in a dedicated article, and zone 2’s lower cortisol and recovery demand fits that reasoning more directly than a HIIT-heavy week would. If you are new to structured cardio entirely, regardless of phenotype, zone 2 is a reasonable place to build consistency before attempting the vigorous intensity the strongest PCOS trial evidence is built on — adherence over months is what most of these trials actually required to show a result.

How does zone 2 fit if your time is genuinely limited?

If you can realistically commit to only two or three sessions a week, the trial evidence argues for spending that limited time at the intensity with the strongest confirmed effect rather than spreading it across a lower-intensity zone with a thinner PCOS-specific evidence base. Zone 2’s case for additional volume assumes you have the time to add sessions on top of, not instead of, the higher-evidence work — someone choosing between one weekly zone 2 session and one weekly vigorous session is better served by the vigorous session, based on everything reviewed above. Zone 2 becomes the more reasonable choice specifically when the alternative is doing no additional cardio at all, when joint recovery or overall fatigue makes vigorous sessions unsustainable that week, or when the goal is building a consistent habit before adding intensity — not as a like-for- like substitute when time is the binding constraint.

Who this will not work for

If HOMA-IR or fasting insulin is the specific marker you are trying to move as quickly as possible, zone 2 alone is not the fastest-evidenced lever — the pooled trial data favours vigorous intensity for that specific outcome, and building a plan around zone 2 exclusively will likely move that marker more slowly than the evidence supports being necessary. It also will not replace strength training’s separate hormonal and body-composition effects, since zone 2 is an aerobic intensity classification, not a substitute for resistance work. And if you are managing a diagnosed cardiac condition, heart-rate-zone training of any kind needs a clinician’s guidance on safe intensity ranges before self-estimating from a formula.

What to actually do with this

Given the honest state of the evidence, the defensible plan is not “zone 2 instead of vigorous” or “vigorous instead of zone 2” — it is both, weighted by what each currently has behind it. Vigorous intensity carries the largest, most statistically confirmed PCOS-specific effect on HOMA-IR available in the literature, so it earns the anchor slots in a week if your primary goal is insulin resistance specifically. Zone 2 earns the additive slots: sessions that build weekly volume, support recovery between harder efforts, and carry a documented — if differently measured — PCOS-specific autonomic benefit of their own. Neither claim requires overstating what a single training zone can do alone, and neither requires waiting for a zone 2-specific PCOS trial that does not yet exist before starting a sustainable aerobic habit.

A practical starting point: two vigorous or interval sessions a week, sized to the trial protocols behind the 36% HOMA-IR figure above, and two to three zone 2 sessions of 30 to 45 minutes, increasing duration before frequency as tolerance builds. Track how you feel and whether the sessions are sustainable over months — adherence, not a specific heart-rate number, is what every trial cited in this article actually required to produce its result.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Nothing about the exercise-intensity evidence above changed with the rename — this article uses PCOS because that is still the term most readers search.

For the realistic timeline of when any of these changes actually show up on a lab test, how long exercise takes to help PCOS is covered separately, and both sit inside the full PCOS exercise and lifestyle guide.

Common questions

  • Is zone 2 cardio good for PCOS?

    No PCOS-specific trial has tested zone 2 as its own protocol. The mechanism — skeletal muscle glucose uptake, which handles about 80% of insulin-driven glucose clearance — supports it as a reasonable lever, but the strongest PCOS trial evidence sits at vigorous intensity, which cut HOMA-IR by 36% across 11 pooled trials.
  • What heart rate is zone 2 for PCOS?

    The same general estimate used outside PCOS: roughly 60-70% of estimated maximum heart rate, or a pace where you can hold a full conversation without gasping. No PCOS-specific heart-rate-zone validation exists, so these are general exercise-physiology estimates, not a PCOS-tuned number.
  • Does zone 2 cardio lower insulin resistance in PCOS?

    Not proven directly. The closest matched evidence, moderate-intensity steady-state exercise pooled across 16 studies, showed only a non-significant trend toward improved HOMA-IR. Vigorous intensity, a higher zone than zone 2, is the modality with a statistically significant, sizeable effect in PCOS trials.
  • Should I do zone 2 or HIIT for PCOS?

    Trial evidence favours higher intensity for insulin resistance specifically, but zone 2 carries a lower recovery cost and can support more total weekly volume. A reasonable plan combines both: vigorous or HIIT sessions for the strongest evidenced effect, zone 2 sessions as additive, sustainable volume.
  • How do I find my zone 2 without a lab test?

    The talk test is the simplest method: if you can speak in full sentences but not sing comfortably, you are likely near zone 2. A formula estimate (220 minus age, then 60-70% of that) is a reasonable second option, though individual variation from the formula is real.

More on this

Sources

  1. 1.DeFronzo RA, Tripathy D. Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes. Diabetes Care. 2009.
  2. 2.Honka MJ, Latva-Rasku A, Bucci M, et al. Insulin-Stimulated Glucose Uptake in Skeletal Muscle, Adipose Tissue and Liver: A Positron Emission Tomography Study. Eur J Endocrinol. 2018.
  3. 3.Patten RK, Boyle RA, Moholdt T, et al. Exercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front Physiol. 2020.
  4. 4.Richards CT, Meah VL, James PE, Rees DA, Lord RN. HIIT'ing or MISS'ing the Optimal Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of High- Versus Moderate-Intensity Exercise Prescription. Front Physiol. 2021.
  5. 5.Tan Y, Liu Y, Koga A, et al. The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with Polycystic Ovarian Syndrome: A Network Meta-Analysis Study. Healthcare (Basel). 2025.
  6. 6.Van Proeyen K, Szlufcik K, Nielens H, et al. Training in the Fasted State Improves Glucose Tolerance During Fat-Rich Diet. The Journal of Physiology. 2010.
  7. 7.Sá JC, Costa EC, da Silva E, et al. Aerobic Exercise Improves Cardiac Autonomic Modulation in Women With Polycystic Ovary Syndrome. Int J Cardiol. 2016.
  8. 8.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine Metabolic Ovarian Syndrome, the New Name for Polycystic Ovary Syndrome: A Multistep Global Consensus Process. Lancet. 2026.

Find your PCOS type

Loading the questions…